Legal & General Group
RPTP

Legal & General Group’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Legal & General Group’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,699
Closed -$96K – 3336
2016
Q3 		$96K Sell
10,699
-4,257
-28% -$30.3K ﹤0.01% 2235
2016
Q2 		$79K Hold
14,956
– – ﹤0.01% 2231
2016
Q1 		$67K Buy
14,956
+4,771
+47% +$19.2K ﹤0.01% 2285
2015
Q4 		$53K Hold
10,185
– – ﹤0.01% 2438
2015
Q3 		$60K Hold
10,185
– – ﹤0.01% 2358
2015
Q2 		$160K Hold
10,185
– – ﹤0.01% 1843
2015
Q1 		$116K Hold
10,185
– – ﹤0.01% 1943
2014
Q4 		$109K Hold
10,185
– – ﹤0.01% 1913
2014
Q3 		$102K Buy
+10,185
New +$104K ﹤0.01% 1877

Legal & General Group's RPTP Position: Q4 2016 in Review

Legal & General Group sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 10,699 shares — an estimated $96K sold.

Legal & General Group first reported a position in RPTP in Q3 2014 and held it in 9 quarters. The position peaked at $160K in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Legal & General Group reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Legal & General Group sold 10,699 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $96K.
  • Legal & General Group first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2014 and held it in 9 quarters.
  • Legal & General Group's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $160K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Legal & General Group's 13F filing for Q4 2016, filed 13 Feb 2017.